icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
All-Oral Therapy With Sofosbuvir Plus Ribavirin For the Treatment of HCV Genotype 1, 2, and 3 Infection in Patients Co-infected With HIV (PHOTON-1)
 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
 
Mark Sulkowski1, Maribel Rodriguez-Torres2, Jacob Lalezari3, W. Jeffrey Fessel4, Karam Mounzer5, Margaret Shuhart6, Annie Luetkemeyer7, David Asmuth8, Anuj Gaggar9, Liyun Ni9, Evguenia Svarovskaia9, Bill Symonds9, John McHutchison9, Susanna Naggie10, Douglas Dieterich11
1Johns Hopkins University, Baltimore, MD; 2Fundacion De Investigacion San Juan, PR; 3Quest Clinical Research, San Francisco, CA; 4Kaiser Permanente, San Francisco, CA; 5Philadelphia FIGHT, Philadelphia, PA; 6Harborview Medical Center, University of Washington, Seattle, WA;
7San Francisco General Hospital, University of California, San Francisco, CA; 8University of California Davis Medical Center in Sacramento, CA; 9Gilead Sciences, Foster City, CA; 10Duke Clinical Research Institute, Durham, NC; 11Mount Sinai School of Medicine, New York, NY

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif